Posted by Michael Wonder on 09 Dec 2019
EMA publishes agenda for 9-12 December CHMP meeting
9 December 2019 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue initial opinions for the following technologies:
- Adalimumab
- Azacitidine
- Brolucizumab
- Dexmedetomidine
- Enasidenib
- Imipenem monohydrate with cilastatin sodium and relebactam
